MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejso.2023.06.002

Медицинская библиотека · European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology · 2023

PET-CT underestimates the true pathological extent of disease at lymphadenectomy for melanoma patients after systemic therapy.

Mor Eyal, Schtrechman Gal, Nizri Eran, Shimonovitz Michal, Asher Nethanel, Ben-Betzalel Guy, Grynberg Shirly, Stoff Ronen, Miodovnik Mor, Adileh Mohammad, Ben-Yaacov Almog, Steinberg Yael, Shapira Ronnie, Schachter Jacob, Lahat Guy, Nissan Aviram, Zippel Douglas, Laks Shachar

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Modern systemic therapy has revolutionized the treatment of melanoma. Currently, patients with clinically involved lymph nodes require lymphadenectomy with associated morbidities. Positron Emission Tomography - Computed Tomography (PET-CT) has demonstrated accuracy in melanoma detection and response to therapy. We aimed to identify whether a PET-CT directed lymphatic resection after systemic therapy is oncologically sound.

MATERIALS AND

METHODS

Retrospective review of patients who underwent lymphadenectomy after systemic therapy for melanoma with a preoperative PET-CT. Examined demographic, clinical, and perioperative parameters including extent of disease, systemic therapy and response, and PET-CT findings compared to pathological outcomes. We compared patients with "as or less than expected" outcomes on pathology against those with "more than expected" pathological outcomes.

RESULTS

Thirty-nine patients met inclusion criteria. In 28 (71.8%), pathological outcomes were "as or less than expected" by PET-CT, and in 11 (28.2%) pathological outcome were "more than expected". "More than expected" occurred more frequently with advanced disease at presentation with 75% presenting with regional/metastatic disease versus only 42.9% in the "as or less than expected" group (p = 0.015). Poor response to therapy also trended towards the "more than expected" group with only 27.3% favorable response versus 53.6% favorable response in the "as or less than expected" group, not statistically significant. Extent of disease on imaging failed to predict pathological concordance.

CONCLUSION

PET-CT underestimates pathological extent of disease in the lymphatic basin in 30% of patients after systemic therapy. We failed to identify predictors of more extensive disease and warn against limited PET-CT directed lymphatic resections.

Для цитирования: Mor Eyal, Schtrechman Gal, Nizri Eran, Shimonovitz Michal, Asher Nethanel, Ben-Betzalel Guy, Grynberg Shirly, Stoff Ronen, Miodovnik Mor, Adileh Mohammad, Ben-Yaacov Almog, Steinberg Yael, Shapira Ronnie, Schachter Jacob, Lahat Guy, Nissan Aviram, Zippel Douglas, Laks Shachar. PET-CT underestimates the true pathological extent of disease at lymphadenectomy for melanoma patients after systemic therapy.. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2023. DOI: 10.1016/j.ejso.2023.06.002.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.